EUVIMEDOpdag EUVIMED
Crossref

NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer

Lei Zhou iD, Yue Fei, Ziyi Wang, Xiaohui Wang, Luya Zhu, Furong Zhao, Ni Duan, Yixuan Wang, Jing Wang, Wenying Zhong iD, Rui Wang iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c14869 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2026. Written by Lei Zhou and 10 co-authors. Institution: School of Science, China Pharmaceutical University, Nanjing211198, China. Major MEDLINE topics: Prodrugs, Colorectal Neoplasms, Fluorouracil, Nanoparticles. 42 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Colorectal cancer (CRC) remains a leading cause of cancer mortality worldwide. 5-Fluorouracil (5-FU) is a first-line chemotherapeutic widely used in CRC treatment, but its systemic administration often causes severe toxicity due to uncontrolled biodistribution. Herein, we present near-infrared (NIR)-activated enteric prodrug microparticles, HPMCP@L-UCNPs-ONB-5-FU, which enable spatiotemporally controlled release of 5-FU in the colon. The photocleavable prodrug o-nitrobenzyl-5-fluorouracil (ONB-5-FU) is conjugated to large upconversion nanoparticles (L-UCNPs) and encapsulated within the enteric polymer hydroxypropyl methylcellulose phthalate (HPMCP) to resist gastric degradation. After oral administration, low-power 980 nm excitation yields 800 nm emission for bioimaging, whereas high-power excitation generates strong 365 nm emission that cleaves the ONB linker and locally releases active 5-FU. In vitro studies confirmed light-gated and power-dependent drug release, while cellular and orthotopic CRC studies demonstrated potent tumor inhibition with minimal systemic toxicity. Overall, this work establishes a precise and biocompatible NIR-controlled prodrug activation paradigm for oral chemotherapy of CRC.

Subjects

MeSH terms (MEDLINE)

ProdrugsColorectal NeoplasmsFluorouracilNanoparticlesHumansAnimalsMiceInfrared RaysDrug LiberationMice, Nude

Author keywords

NIR-triggered prodrugcolorectal cancerenteric prodrug microparticlesoral drug deliveryupconversion nanoparticles

Substances

ProdrugsFluorouracil

Authors and institutions

  • School of Science, China Pharmaceutical University, Nanjing211198, China.
  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing210096, China.

ORCID profiles: Lei Zhou, Wenying Zhong, Rui Wang

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Cite

APA

Zhou, L., Fei, Y., Wang, Z., Wang, X., Zhu, L., Zhao, F., Duan, N., Wang, Y., Wang, J., Zhong, W., & Wang, R. (2026). NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14869

Vancouver

Zhou L, Fei Y, Wang Z, Wang X, Zhu L, Zhao F, et al. NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14869

BibTeX
@article{Zhou2026,
  author = {Zhou, Lei and Fei, Yue and Wang, Ziyi and Wang, Xiaohui and Zhu, Luya and Zhao, Furong and Duan, Ni and Wang, Yixuan and Wang, Jing and Zhong, Wenying and Wang, Rui},
  title = {NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c14869}
}
Start for free →